Explaining UW Health’s Regeneron clinical trial of COVID-19 drug

UW Health is one of 100 clinical trial sites in the United States using a new antibody cocktail to treat coronavirus patients. Dr. William Hartman, UW Health’s principal investigator for the Regeneron clinical trial, joins Live at Four to talk about the experimental treatment.